Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure

the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver Clinical Trial

Official title:

Relationship of Serological Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01312220
• Other study ID #: 201101061RC
• Status: Recruiting
• Phase: N/A
• First received: March 8, 2011
• Last updated: March 8, 2011
• Start date: February 2011
• Est. completion date: February 2013

Study information

• Verified date: February 2011
• Source: National Taiwan University Hospital
• Contact: CM Ho, MD
• Phone: +88623123456
• Email: miningho[@]ntu.edu.tw
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

To study the correlation of serological growth factors and the hepatic progenitor cells involved in liver regeneration of liver failure.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10
• Est. completion date: February 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

Acute liver failure Received iver transplantation

Exclusion Criteria:

Pregnancy Sepsis Heart failure

Study Design

Observational Model: Cohort

Related Conditions & MeSH terms

• Liver Failure
• Liver Failure, Acute
• the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver

Locations

Country	Name	City	State
Taiwan	NTUH	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan,